Publication:
Ex Vivo and in Vivo Stable Isotope Labelling of Central Carbon Metabolism and Related Pathways With Analysis by LC–MS/MS

No Thumbnail Available

Date

2019-02

Journal Title

Journal ISSN

Volume Title

Publisher

Springer Science and Business Media LLC
The Harvard community has made this article openly available. Please share how this access benefits you.

Research Projects

Organizational Units

Journal Issue

Citation

Yuan, Min, Daniel M. Kremer, He Huang, Susanne B. Breitkopf, Issam Ben-Sahra, Brendan Manning, Costas A. Lyssiotis et al. "Ex Vivo and in Vivo Stable Isotope Labelling of Central Carbon Metabolism and Related Pathways With Analysis by LC–MS/MS." Nature Protocols 14, no. 2 (2019): 313-330. DOI: 10.1038/s41596-018-0102-x

Research Data

Abstract

Targeted tandem mass spectrometry (LC–MS/MS) has been extremely useful for profiling small molecules extracted from biological sources, such as cells, bodily fluids and tissues. Here, we present a protocol for analysing incorporation of the non-radioactive stable isotopes carbon-13 (13C) and nitrogen-15 (15N) into polar metabolites in central carbon metabolism and related pathways. Our platform utilizes selected reaction monitoring (SRM) with polarity switching and amide hydrophilic interaction liquid chromatography (HILIC) to capture transitions for carbon and nitrogen incorporation into selected metabolites using a hybrid triple quadrupole (QQQ) mass spectrometer. This protocol represents an extension of a previously published protocol for targeted metabolomics of unlabeled species and has been used extensively in tracing the metabolism of nutrients such as 13C-labeled glucose, 13C-glutamine and 15N-glutamine in a variety of biological settings (e.g., cell culture experiments and in vivo mouse labelling via i.p. injection). SRM signals are integrated to produce an array of peak areas for each labelling form that serve as the output for further analysis. The processed data are then used to obtain the degree and distribution of labelling of the targeted molecules (termed fluxomics). Each method can be customized on the basis of known unlabeled Q1/Q3 SRM transitions and adjusted to account for the corresponding 13C or 15N incorporation. The entire procedure takes ~6–7 h for a single sample from experimental labelling and metabolite extraction to peak integration.

Description

Keywords

Research Subject Categories::NATURAL SCIENCES::Chemistry::Biochemistry, Research Subject Categories::NATURAL SCIENCES::Biology::Cell and molecular biology

Terms of Use

Metadata Only

Endorsement

Review

Supplemented By

Referenced By

Related Stories